Objective: In contrast to the clinical evidence, experimental studies showed that chronic hypoxia (CH) confers a certain degree of protection against ischaemia-reperfusion damage. We studied the effects of daily reoxygenation during CH (CHReox) on hearts exposed to ischaemia-reperfusion. We also separated the intrinsic effects on the myocardium of CH and CHReox from those related to circulatory and nervous factors. Methods: Fifty-one Sprague-Dawley rats were maintained for 15 days under CH (10% O2) or CHReox (10% O2 + 1 h day-1 exposure to air). Normoxic (N, 21% O2) rats were the control. The animals were randomly assigned to one of the three following protocols: (1) protocol A: hearts (n = 7 per group) were subjected to 30-min occlusion of the left anterior descending (LAD) coronary artery followed by 3-h reperfusion, with measurement of the injury by tetrazolium staining; (2) protocol B: the end-diastolic pressure (EDP) and left ventricular developed pressure × heart rate (LVDP × HR) were measured in Langendorff-perfused isolated hearts (n = 5 per group) during 30-min global ischaemia and 45-min reperfusion; and (3) protocol C: hearts (n = 5 per group) were frozen for the determination of levels of endothelial nitric oxide synthase (eNOS) by Western blotting. Results: CHReox hearts displayed greater phosphorylation of the eNOS and enhanced plasma level of nitrates and nitrites in comparison to CH hearts (P < 0.0001, Bonferroni's post-test). The infarct size was greater in CH than in N hearts (P < 0.0001, Bonferroni's post-test) while it was reduced in CHReox in comparison to CH and N hearts (P < 0.0001). At the end of reperfusion, EDP was higher in CH than CHReox and N hearts (P = 0.01, Bonferroni's post-test) while LVDP × HR was higher in CHReox and N than in CH hearts (P = 0.03, Bonferroni's post-test). Conclusions: Exposure to CH results in impairment of myocardial tolerance to ischaemia-reperfusion, greater injury and reduced recovery of performance, in agreement with clinical evidence. Infarct size, diastolic contracture and myocardial performance have been reduced, respectively, by 63%, 64% and 151% with daily reoxygenation compared with chronic hypoxia by accelerating intrinsic adaptive changes.

Daily reoxygenation decreases myocardial injury and improves post-ischemic recovery after chronic hypoxia / G. Milano, A.F. Corno, M. Samaja, S. Morel, G. Vassalli, L.K. von Segesser. - In: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. - ISSN 1010-7940. - 37:4(2010), pp. 942-949.

Daily reoxygenation decreases myocardial injury and improves post-ischemic recovery after chronic hypoxia

M. Samaja;
2010

Abstract

Objective: In contrast to the clinical evidence, experimental studies showed that chronic hypoxia (CH) confers a certain degree of protection against ischaemia-reperfusion damage. We studied the effects of daily reoxygenation during CH (CHReox) on hearts exposed to ischaemia-reperfusion. We also separated the intrinsic effects on the myocardium of CH and CHReox from those related to circulatory and nervous factors. Methods: Fifty-one Sprague-Dawley rats were maintained for 15 days under CH (10% O2) or CHReox (10% O2 + 1 h day-1 exposure to air). Normoxic (N, 21% O2) rats were the control. The animals were randomly assigned to one of the three following protocols: (1) protocol A: hearts (n = 7 per group) were subjected to 30-min occlusion of the left anterior descending (LAD) coronary artery followed by 3-h reperfusion, with measurement of the injury by tetrazolium staining; (2) protocol B: the end-diastolic pressure (EDP) and left ventricular developed pressure × heart rate (LVDP × HR) were measured in Langendorff-perfused isolated hearts (n = 5 per group) during 30-min global ischaemia and 45-min reperfusion; and (3) protocol C: hearts (n = 5 per group) were frozen for the determination of levels of endothelial nitric oxide synthase (eNOS) by Western blotting. Results: CHReox hearts displayed greater phosphorylation of the eNOS and enhanced plasma level of nitrates and nitrites in comparison to CH hearts (P < 0.0001, Bonferroni's post-test). The infarct size was greater in CH than in N hearts (P < 0.0001, Bonferroni's post-test) while it was reduced in CHReox in comparison to CH and N hearts (P < 0.0001). At the end of reperfusion, EDP was higher in CH than CHReox and N hearts (P = 0.01, Bonferroni's post-test) while LVDP × HR was higher in CHReox and N than in CH hearts (P = 0.03, Bonferroni's post-test). Conclusions: Exposure to CH results in impairment of myocardial tolerance to ischaemia-reperfusion, greater injury and reduced recovery of performance, in agreement with clinical evidence. Infarct size, diastolic contracture and myocardial performance have been reduced, respectively, by 63%, 64% and 151% with daily reoxygenation compared with chronic hypoxia by accelerating intrinsic adaptive changes.
Settore BIO/10 - Biochimica
2010
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/139927
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 18
  • OpenAlex ND
social impact